![Report Northern America - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/northern-america-vaccines-for-human-medicine-market-analysis-forecast-size-trends-and-insights.webp)
Northern America - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingNorthern America: Vaccine Market 2024
Vaccine Market Size in Northern America
In 2023, the North American vaccine market decreased by X% to $X for the first time since 2017, thus ending a five-year rising trend. In general, consumption, however, showed a prominent increase. The level of consumption peaked at $X in 2022, and then shrank in the following year.
Vaccine Production in Northern America
In value terms, vaccine production skyrocketed to $X in 2023 estimated in export price. Over the period under review, production recorded a remarkable increase. The most prominent rate of growth was recorded in 2021 with an increase of X%. As a result, production reached the peak level of $X. From 2022 to 2023, production growth failed to regain momentum.
Vaccine Exports
Exports in Northern America
In 2023, the amount of vaccines for human medicine exported in Northern America skyrocketed to X tons, growing by X% against the previous year. In general, exports saw a resilient increase. The pace of growth appeared the most rapid in 2021 with an increase of X%. As a result, the exports attained the peak of X tons. From 2022 to 2023, the growth of the exports remained at a somewhat lower figure.
In value terms, vaccine exports skyrocketed to $X in 2023. Overall, exports saw a prominent increase. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. As a result, the exports attained the peak of $X. From 2022 to 2023, the growth of the exports failed to regain momentum.
Exports by Country
The United States prevails in exports structure, finishing at X tons, which was approx. X% of total exports in 2023. Canada (X tons) took a minor share of total exports.
The United States was also the fastest-growing in terms of the vaccines for human medicine exports, with a CAGR of X% from 2012 to 2023. Canada (X%) illustrated a downward trend over the same period. While the share of the United States (X p.p.) increased significantly in terms of the total exports from 2012-2023, the share of Canada (X p.p.) displayed negative dynamics.
In value terms, the United States ($X) remains the largest vaccine supplier in Northern America, comprising X% of total exports. The second position in the ranking was taken by Canada ($X), with a X% share of total exports.
In the United States, vaccine exports increased at an average annual rate of X% over the period from 2012-2023.
Export Prices by Country
In 2023, the export price in Northern America amounted to $X,844 per ton, approximately mirroring the previous year. Overall, the export price, however, posted a strong increase. The pace of growth appeared the most rapid in 2021 when the export price increased by X%. The level of export peaked at $X,322 per ton in 2022, and then fell modestly in the following year.
There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was the United States ($X,392 per ton), while Canada amounted to $X per ton.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the United States (X%).
Vaccine Imports
Imports in Northern America
In 2023, purchases abroad of vaccines for human medicine decreased by X% to X tons for the first time since 2020, thus ending a two-year rising trend. In general, imports, however, posted a buoyant increase. The pace of growth appeared the most rapid in 2021 when imports increased by X% against the previous year. Over the period under review, imports attained the maximum at X tons in 2022, and then shrank in the following year.
In value terms, vaccine imports declined to $X in 2023. Over the period under review, imports, however, posted a prominent increase. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, imports attained the maximum at $X in 2022, and then declined in the following year.
Imports by Country
In 2023, Canada (X tons) represented the main importer of vaccines for human medicine, constituting X% of total imports. It was distantly followed by the United States (X tons), creating a X% share of total imports.
From 2012 to 2023, the biggest increases were recorded for Canada (with a CAGR of X%).
In value terms, the United States ($X) constitutes the largest market for imported vaccines for human medicine in Northern America, comprising X% of total imports. The second position in the ranking was held by Canada ($X), with a X% share of total imports.
From 2012 to 2023, the average annual rate of growth in terms of value in the United States stood at X%.
Import Prices by Country
In 2023, the import price in Northern America amounted to $X per kg, falling by X% against the previous year. Over the period under review, the import price, however, recorded prominent growth. The growth pace was the most rapid in 2015 an increase of X% against the previous year. The level of import peaked at $X per kg in 2020; however, from 2021 to 2023, import prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was the United States ($X per kg), while Canada amounted to $X per kg.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Canada (X%).
Source: IndexBox Platform
This report provides an in-depth analysis of the vaccine market in Northern America. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Bermuda
- Canada
- Greenland
- Saint Pierre and Miquelon
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in Northern America, split by region and country
- Trade (exports and imports) in Northern America
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Bermuda
- Canada
- Greenland
- Saint Pierre and Miquelon
- United States
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the vaccine market in Asia.
This report provides an in-depth analysis of the vaccine market in the U.S..
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the vaccine market in the EU.
This report provides an in-depth analysis of the global vaccine market.